NCT05147948

Brief Summary

The primary aim of this study is to investigate the effect of Internet-delivered Acceptance and commitment therapy for PTSD and comorbid chronic pain using a randomized controlled trial with waitlist control.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
19mo left

Started Oct 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Oct 2021Dec 2027

First Submitted

Initial submission to the registry

October 8, 2021

Completed
10 days until next milestone

Study Start

First participant enrolled

October 18, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 7, 2021

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2026

Expected
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2027

Last Updated

February 19, 2026

Status Verified

February 1, 2026

Enrollment Period

5 years

First QC Date

October 8, 2021

Last Update Submit

February 16, 2026

Conditions

Keywords

PTSDChronic painACT

Outcome Measures

Primary Outcomes (1)

  • PTSD symptom severity as measured by the the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) and the Life Events Checklist (LEC-5)

    (changes between assessments)

    Baseline, mid-treatment (3 weeks), mid-treatment (7 weeks), two-week-post treatment, 3 month-follow-up, 12-month follow-up.

Secondary Outcomes (14)

  • Anxiety and depression as measured by the Hospital Anxiety and Depression Scale (HADS)

    Baseline, two-week-post treatment, 3 month-follow-up, 12-month follow-up.

  • Psychological inflexibility as measured by the Psychological Inflexibility in Pain Scale (PIPS)

    Baseline, two-week-post treatment, 3 month-follow-up, 12-month follow-up.

  • General acceptance as measured by the Swedish Acceptance and Action Questionnaire (SAAQ)

    Baseline, mid-treatment (3 weeks), mid-treatment (7 weeks), two-week-post treatment, 3 month-follow-up, 12-month follow-up.

  • Posttraumatic Cognitions as measured by the Posttraumatic Cognitions Inventory (PTCI)

    Baseline, two-week-post treatment, 3 month-follow-up, 12-month follow-up.

  • Pain interference as measured by the Multidimensional Pain Inventory (MPI)

    Baseline, two-week-post treatment, 3 month-follow-up, 12-month follow-up.

  • +9 more secondary outcomes

Study Arms (2)

Treatment

EXPERIMENTAL

Internet delivered Acceptance and Commitment Therapy for PTSD and Chronic Pain, supported by a psychologist

Behavioral: iACT for PTSD and Chronic Pain

Waitlist

NO INTERVENTION

Waitlist for 12 weeks.

Interventions

The participants will go through internet-based Acceptance and Commitment Therapy which mainly involves: 1) Exercises focused on developing acceptance, defusion, and mindfulness skills; 2) Identification of personal values as well as valued steps and feared situations to approach during the program 3) Written exposure exercises focusing on the traumatic memory adapted from Written exposure therapy (WET) using an ACT-based framework. The treatment is delivered on a safe internet platform. Participants have planned telephone contact with their assigned psychologist 3 times during the program and can also contact their psychologist via a message system in the platform and expect answer within 48 hours.

Treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • a CAPS of ≥25
  • subjected to single traumatic events
  • were able to understand Swedish
  • had symptoms of chronic pain that interfered significantly with everyday life
  • were fully examined medically and had received medical treatment if indicated
  • were able to be an active part of the rehabilitation process, regain functioning in different life areas and participate in treatment interventions for approximately 5 hours every week
  • stable dose of medication
  • able to read and write in Swedish
  • had access to a smart phone or computer with internet access

You may not qualify if:

  • repeated and extensive traumatic events
  • had other acute or severe psychiatric disorders or symptoms that warranted designation as the primary disorder (ongoing substance dependence, untreated bipolar disorder, OCD, psychotic symptoms, severe depression)
  • were actively abusing analgesic medications (including narcotics), alcohol or other drugs
  • had great difficulty to harbour and handle strong emotions that could lead to emotional outbursts or self-harming behavior
  • had health risks due to medical reasons
  • had social or economic difficulties or lack of social support that hindered behavior change
  • current severe suicidal ideation that warranted immediate intervention (indicated by the MINI and a score of 3 to item 9 of the Patient Health Questionnaire 9-item version (PHQ9))

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Pain Pehabilitation, Skåne University Hospital

Lund, 22241, Sweden

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticChronic Pain

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Sophia Åkerblom, PhD

CONTACT

Sanna Stacke

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomised controlled trial with waitlist control.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 8, 2021

First Posted

December 7, 2021

Study Start

October 18, 2021

Primary Completion (Estimated)

October 18, 2026

Study Completion (Estimated)

December 18, 2027

Last Updated

February 19, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations